MS

Matthew G. Stanton

ST Sirna Therapeutics: 4 patents #1 of 23Top 5%
MO Modernatx: 1 patents #16 of 31Top 55%
Merck: 1 patents #424 of 1,083Top 40%
📍 Cambridge, MA: #46 of 1,336 inventorsTop 4%
🗺 Massachusetts: #363 of 12,682 inventorsTop 3%
Overall (2018): #18,603 of 503,207Top 4%
6
Patents 2018

Issued Patents 2018

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
10072057 Alternative nucleic acid molecules containing reduced uracil content and uses thereof Stephen Hoge, William Issa, Edward J. Miracco, Jennifer Nelson, John Reynders 2018-09-11
10010562 Dual molecular delivery of oligonucleotides and peptide containing conjugates Steven L. Colletti, Thomas J. Tucker, David M. Tellers, Boyoung Kim, Rob Burke +4 more 2018-07-03
9981907 Low molecular weight cationic lipids for oligonucleotide delivery Steven L. Colletti 2018-05-29
9970005 RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) Mark Cancilla, James J. Cunningham, William Michael Flanagan, Henry J. Haringsma, Denise M. Kenski +2 more 2018-05-15
9896688 Short interfering nucleic acid (siNA) molecules containing a 2′ internucleoside linkage Wonsuk Chang, Erin N. Guidry, Daniel Zewge 2018-02-20
9861589 Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide delivery Steven L. Colletti 2018-01-09